622 related articles for article (PubMed ID: 15078899)
1. c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor-induced apoptosis.
Mathas S; Lietz A; Anagnostopoulos I; Hummel F; Wiesner B; Janz M; Jundt F; Hirsch B; Jöhrens-Leder K; Vornlocher HP; Bommert K; Stein H; Dörken B
J Exp Med; 2004 Apr; 199(8):1041-52. PubMed ID: 15078899
[TBL] [Abstract][Full Text] [Related]
2. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.
Fulda S; Meyer E; Debatin KM
Cancer Res; 2000 Jul; 60(14):3947-56. PubMed ID: 10919673
[TBL] [Abstract][Full Text] [Related]
3. Constitutive expression of c-FLIP in Hodgkin and Reed-Sternberg cells.
Thomas RK; Kallenborn A; Wickenhauser C; Schultze JL; Draube A; Vockerodt M; Re D; Diehl V; Wolf J
Am J Pathol; 2002 Apr; 160(4):1521-8. PubMed ID: 11943736
[TBL] [Abstract][Full Text] [Related]
4. Expression of the cellular FLICE-inhibitory protein (c-FLIP) protects Hodgkin's lymphoma cells from autonomous Fas-mediated death.
Dutton A; O'Neil JD; Milner AE; Reynolds GM; Starczynski J; Crocker J; Young LS; Murray PG
Proc Natl Acad Sci U S A; 2004 Apr; 101(17):6611-6. PubMed ID: 15096587
[TBL] [Abstract][Full Text] [Related]
5. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
Ganten TM; Haas TL; Sykora J; Stahl H; Sprick MR; Fas SC; Krueger A; Weigand MA; Grosse-Wilde A; Stremmel W; Krammer PH; Walczak H
Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837
[TBL] [Abstract][Full Text] [Related]
6. Fas-associated death domain protein (FADD) and caspase-8 mediate up-regulation of c-Fos by Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) via a FLICE inhibitory protein (FLIP)-regulated pathway.
Siegmund D; Mauri D; Peters N; Juo P; Thome M; Reichwein M; Blenis J; Scheurich P; Tschopp J; Wajant H
J Biol Chem; 2001 Aug; 276(35):32585-90. PubMed ID: 11384965
[TBL] [Abstract][Full Text] [Related]
7. Induction of apoptosis in 9-nitrocamptothecin-treated DU145 human prostate carcinoma cells correlates with de novo synthesis of CD95 and CD95 ligand and down-regulation of c-FLIP(short).
Chatterjee D; Schmitz I; Krueger A; Yeung K; Kirchhoff S; Krammer PH; Peter ME; Wyche JH; Pantazis P
Cancer Res; 2001 Oct; 61(19):7148-54. PubMed ID: 11585748
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Fas-mediated apoptosis by the B cell antigen receptor through c-FLIP.
Wang J; Lobito AA; Shen F; Hornung F; Winoto A; Lenardo MJ
Eur J Immunol; 2000 Jan; 30(1):155-63. PubMed ID: 10602037
[TBL] [Abstract][Full Text] [Related]
9. Resistance of human ovarian cancer cells to tumor necrosis factor alpha is a consequence of nuclear factor kappaB-mediated induction of Fas-associated death domain-like interleukin-1beta-converting enzyme-like inhibitory protein.
Xiao CW; Yan X; Li Y; Reddy SA; Tsang BK
Endocrinology; 2003 Feb; 144(2):623-30. PubMed ID: 12538625
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of resistance to TRAIL-induced apoptosis in primary B cell chronic lymphocytic leukaemia.
MacFarlane M; Harper N; Snowden RT; Dyer MJ; Barnett GA; Pringle JH; Cohen GM
Oncogene; 2002 Oct; 21(44):6809-18. PubMed ID: 12360407
[TBL] [Abstract][Full Text] [Related]
11. The role of c-FLIP in modulation of CD95-induced apoptosis.
Scaffidi C; Schmitz I; Krammer PH; Peter ME
J Biol Chem; 1999 Jan; 274(3):1541-8. PubMed ID: 9880531
[TBL] [Abstract][Full Text] [Related]
12. Adhesion-mediated intracellular redistribution of c-Fas-associated death domain-like IL-1-converting enzyme-like inhibitory protein-long confers resistance to CD95-induced apoptosis in hematopoietic cancer cell lines.
Shain KH; Landowski TH; Dalton WS
J Immunol; 2002 Mar; 168(5):2544-53. PubMed ID: 11859150
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of CD95 apoptotic signaling by interferon-gamma in human osteoarthritic chondrocytes is associated with increased expression of FLICE inhibitory protein.
Grassi F; Piacentini A; Cristino S; Toneguzzi S; Facchini A; Lisignoli G
Arthritis Rheum; 2004 Feb; 50(2):498-506. PubMed ID: 14872492
[TBL] [Abstract][Full Text] [Related]
14. CD95-mediated apoptosis is impaired at receptor level by cellular FLICE-inhibitory protein (long form) in wild-type p53 human ovarian carcinoma.
Mezzanzanica D; Balladore E; Turatti F; Luison E; Alberti P; Bagnoli M; Figini M; Mazzoni A; Raspagliesi F; Oggionni M; Pilotti S; Canevari S
Clin Cancer Res; 2004 Aug; 10(15):5202-14. PubMed ID: 15297424
[TBL] [Abstract][Full Text] [Related]
15. Role of antiapoptotic proteins in tumor necrosis factor-related apoptosis-inducing ligand and cisplatin-augmented apoptosis.
Kim JH; Ajaz M; Lokshin A; Lee YJ
Clin Cancer Res; 2003 Aug; 9(8):3134-41. PubMed ID: 12912965
[TBL] [Abstract][Full Text] [Related]
16. Fas-associated protein with death domain (FADD)-independent recruitment of c-FLIPL to death receptor 5.
Jin TG; Kurakin A; Benhaga N; Abe K; Mohseni M; Sandra F; Song K; Kay BK; Khosravi-Far R
J Biol Chem; 2004 Dec; 279(53):55594-601. PubMed ID: 15485835
[TBL] [Abstract][Full Text] [Related]
17. Fas-associated death domain protein and caspase-8 are not recruited to the tumor necrosis factor receptor 1 signaling complex during tumor necrosis factor-induced apoptosis.
Harper N; Hughes M; MacFarlane M; Cohen GM
J Biol Chem; 2003 Jul; 278(28):25534-41. PubMed ID: 12721308
[TBL] [Abstract][Full Text] [Related]
18. NFkappaB activation by Fas is mediated through FADD, caspase-8, and RIP and is inhibited by FLIP.
Kreuz S; Siegmund D; Rumpf JJ; Samel D; Leverkus M; Janssen O; Häcker G; Dittrich-Breiholz O; Kracht M; Scheurich P; Wajant H
J Cell Biol; 2004 Aug; 166(3):369-80. PubMed ID: 15289496
[TBL] [Abstract][Full Text] [Related]
19. Bortezomib induces caspase-dependent apoptosis in Hodgkin lymphoma cell lines and is associated with reduced c-FLIP expression: a gene expression profiling study with implications for potential combination therapies.
Zhao X; Qiu W; Kung J; Zhao X; Peng X; Yegappan M; Yen-Lieberman B; Hsi ED
Leuk Res; 2008 Feb; 32(2):275-85. PubMed ID: 17659339
[TBL] [Abstract][Full Text] [Related]
20. Impairment of death-inducing signalling complex formation in CD95-resistant human primary lymphoma B cells.
Lajmanovich A; Irisarri M; Molens JP; Pasquier MA; Sotto JJ; Bensa JC; Leroux D; Plumas J
Br J Haematol; 2004 Mar; 124(6):746-53. PubMed ID: 15009062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
